International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13475 - 13475
Published: Dec. 16, 2024
Targeting
DNA
damage
response
(DDR)
pathways
represents
one
of
the
principal
approaches
in
cancer
therapy.
However,
defects
DDR
mechanisms,
exhibited
by
various
tumors,
can
also
promote
tumor
progression
and
resistance
to
therapy,
negatively
impacting
patient
survival.
Therefore,
identifying
new
molecules
from
natural
extracts
could
provide
a
powerful
source
novel
compounds
for
treatment
strategies.
In
this
context,
we
investigated
role
oleanolic
acid
(OA),
identified
fermented
Aglianico
red
grape
pomace,
modulating
camptothecin
(CPT),
an
inhibitor
topoisomerase
I.
Specifically,
found
that
OA
influence
choice
repair
pathway
upon
CPT
treatment,
shifting
process
homologous
recombination
gene
conversion
single-strand
annealing.
Moreover,
our
data
demonstrate
combining
sub-lethal
concentrations
with
enhances
efficacy
I
inhibition
compared
alone.
Overall,
these
findings
highlight
DDR,
leading
more
mutagenic
increased
sensitivity
HeLa
cell
line.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 3, 2024
Abstract
This
work
examines
the
capacity
of
Naringin
and
Rutin
to
influence
DNA
damage
response
(DDR)
pathway
by
investigating
their
interactions
with
key
DDR
proteins,
including
PARP-1,
ATM,
ATR,
CHK1,
WEE1.
Through
a
combination
in
silico
molecular
docking
vitro
evaluations,
we
investigated
cytotoxic
genotoxic
effects
these
compounds
on
MDA-MB-231
cells,
comparing
them
normal
human
fibroblast
cells
(2DD)
quiescent
(QFC).
The
research
found
that
had
strong
affinities
for
indicating
specifically
regulate
pathways
cancer
cells.
Both
exhibited
preferential
cytotoxicity
towards
while
preserving
vitality
2DD
as
demonstrated
experiments
conducted
at
dose
10
µM.
comet
performed
particularly
QFC
provide
valuable
information
impact
Rutin,
highlighting
targeted
initiation
need
use
precise
cell
models
appropriately
evaluate
toxicity
genotoxicity
is
emphasized
this
discrepancy.
In
addition,
ADMET
drug-likeness
investigations
have
pharmacological
potential
compounds;
however,
they
also
pointed
out
necessity
optimization
improve
therapeutic
profiles.
antioxidant
capabilities
were
assessed
using
DPPH
free
radical
scavenging
assays
concentration
results
confirmed
both
role
reducing
oxidative
stress,
hence
enhancing
anticancer
effects.
Overall,
show
medicines
modulating
treatment.
They
exhibit
selective
sparing
possess
properties.
analysis
enhances
our
understanding
uses
natural
chemicals
treatment,
supporting
more
mechanisms
action
clinical
effectiveness.
Cells,
Journal Year:
2023,
Volume and Issue:
12(7), P. 1038 - 1038
Published: March 29, 2023
The
PARP
inhibitor
(PARPi)
olaparib
is
currently
the
drug
of
choice
for
serous
ovarian
cancer
(OC),
especially
in
patients
with
homologous
recombination
(HR)
repair
deficiency
associated
deleterious
BRCA1/2
mutations.
Unfortunately,
OC
who
fail
to
respond
PARPi
or
relapse
after
treatment
have
limited
therapeutic
options.
To
elucidate
resistance
and
enhance
efficacy
olaparib,
intracellular
factors
exploited
by
cells
achieve
decreased
sensitivity
were
examined.
An
olaparib-resistant
cell
line,
PEO1-OR,
was
established
from
BRCA2MUT
PEO1
cells.
anticancer
activity
action
combined
inhibitors
ATR/CHK1
pathway
(ceralasertib
as
ATRi,
MK-8776
CHK1i)
olaparib-sensitive
-resistant
lines
evaluated.
Whole-exome
sequencing
revealed
that
PEO1-OR
acquire
through
subclonal
enrichment
BRCA2
secondary
mutations
restore
functional
full-length
protein.
Moreover,
upregulate
HR
repair-promoting
(BRCA1,
BRCA2,
RAD51)
PARP1.
Olaparib-inducible
activation
G2/M
arrest
abrogated
Drug
assays
are
less
sensitive
ATRi
CHK1i
agents.
Combined
effective
considering
inhibition
metabolic
activity,
colony
formation,
survival,
accumulation
DNA
double-strand
breaks,
chromosomal
aberrations.
However,
synergistic
antitumor
between
compounds
achievable
Collectively,
display
co-existing
repair-related
mechanisms
confer
which
may
be
effectively
utilized
resensitize
them
via
combination
therapy.
Importantly,
addition
has
potential
overcome
acquired
PARPi.
Strahlentherapie und Onkologie,
Journal Year:
2023,
Volume and Issue:
199(12), P. 1091 - 1109
Published: April 11, 2023
Abstract
Recent
advances
in
understanding
the
tumor’s
biology
line
with
a
constantly
growing
number
of
innovative
technologies
have
prompted
characterization
patients’
individual
malignancies
and
may
display
prerequisite
to
treat
cancer
at
its
patient
tumor
vulnerability.
In
recent
decades,
radiation-
induced
signaling
promoting
local
events
for
radiation
sensitization
were
explored
detail,
resulting
development
novel
molecular
targets.
A
multitude
pharmacological,
genetic,
immunological
principles,
including
small
molecule-
antibody-based
targeted
strategies,
been
developed
that
are
suitable
combined
concepts
(RT)
or
chemoradiation
therapy
(CRT).
Despite
plethora
promising
experimental
preclinical
findings,
however,
so
far,
only
very
limited
clinical
trials
demonstrated
better
outcome
and/or
benefit
when
RT
CRT
agents.
The
current
review
aims
summarize
progress
therapies
targeting
oncogenic
drivers,
DNA
damage
cell
cycle
response,
apoptosis
pathways,
adhesion
molecules,
hypoxia,
microenvironment
impact
refractoriness
boost
response.
addition,
we
will
discuss
nanotechnology,
e.g.,
RNA
protein-degrading
proteolysis-targeting
chimeras
(PROTACs)
open
new
ways
from
molecular-targeted
approaches
improved
efficacy.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(1), P. 63 - 63
Published: Jan. 8, 2025
Melanoma
is
the
most
aggressive
and
lethal
skin
cancer
that
affects
thousands
of
people
worldwide.
Ruthenium
complexes
have
shown
promising
results
as
chemotherapeutics,
offering
several
advantages
over
platinum
drugs,
such
potent
efficacy,
low
toxicity,
less
drug
resistance.
Additionally,
anthraquinone
derivatives
broad
therapeutic
applications,
including
melanoma.
Thus,
two
new
ruthenium
with
1-hydroxy-9,10-anthraquinone
were
obtained:
trans-[Ru(HQ)(PPh3)2(bipy)]PF6
(1)
cis-[RuCl2(HQ)(dppb)]
(2),
where
HQ
=
1-hydroxy-9,10-anthraquinone,
PPh3
triphenylphospine,
bipy
2,2'-bipyridine,
PF6
hexafluorophosphate,
dppb
1,4-bis(diphenylphosphine)butane.
The
characterized
by
infrared
(IR),
UV-vis,
1H,
13C{1H},
31P{1H}
NMR
spectroscopies,
molar
conductivity,
cyclic
voltammetry,
elemental
analysis.
Furthermore,
density
functional
theory
(DFT)
calculations
performed.
Compound
(2)
was
determined
single-crystal
X-ray
diffraction,
which
confirms
bidentate
coordination
mode
through
carbonyl
phenolate
oxygens.
DNA-binding
experiments
yielded
constants
105
M-1
(Kb
6.93
×
for
1.60
(2))
demonstrate
both
can
interact
DNA
intercalation,
electrostatic
attraction,
or
hydrogen
bonding.
cytotoxicity
profiles
compounds
evaluated
in
human
melanoma
cell
lines
(SK-MEL-147,
CHL-1,
WM1366),
revealing
greater
cytotoxic
activity
on
CHL-1
line
an
IC50
14.50
±
1.09
µM.
Subsequent
studies
showed
inhibits
proliferation
cells
induces
apoptosis,
associated
at
least
part
pro-oxidant
effect
cycle
arrest
G1/S
transition.
Biology,
Journal Year:
2025,
Volume and Issue:
14(2), P. 185 - 185
Published: Feb. 11, 2025
The
Wnt/β-catenin
pathway
takes
part
in
important
cellular
processes
tumor
cells,
such
as
gene
expression,
adhesion,
and
survival.
canonical
is
activated
several
tumors,
β-catenin
its
major
effector.
union
of
Wnt
to
the
co-receptor
complex
causes
inhibition
GSK3β
activity,
thus
preventing
phosphorylation
degradation
β-catenin,
which
accumulates
cytoplasm,
subsequently
be
transported
nucleus
associate
with
transcription
factors.
relationship
between
DNA
damage/repair
mechanisms
has
been
a
focus
for
last
few
years.
Studying
network
interactions
proteins
become
successful
research
field.
This
review
provides
an
overview
participation
their
future
implications
targets
cancer
therapy.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(23), P. 16784 - 16784
Published: Nov. 26, 2023
Elucidating
the
dynamics
of
DNA
repair
proteins
is
essential
to
understanding
mechanisms
that
preserve
genomic
stability
and
prevent
carcinogenesis.
However,
measurement
modeling
protein
at
lesions
via
currently
available
image
analysis
tools
cumbersome.
Therefore,
we
developed
CellTool-a
stand-alone
open-source
software
with
a
graphical
user
interface
for
time-lapse
microscopy
images.
It
combines
data
management,
processing,
mathematical
modeling,
presentation
in
single
package.
Multiple
filters,
segmentation,
particle
tracking
algorithms,
combined
direct
visualization
obtained
results,
make
CellTool
an
ideal
application
comprehensive
dynamics.
This
enables
fitting
kinetic
predefined
or
custom
models.
Importantly,
provides
platform
easy
implementation
packages
written
variety
programing
languages.
Using
CellTool,
demonstrate
ALKB
homolog
2
(ALKBH2)
demethylase
excluded
from
damage
sites
despite
recruitment
its
putative
interaction
partner
proliferating
cell
nuclear
antigen
(PCNA).
Further,
facilitates
straightforward
fluorescence
recovery
after
photobleaching
(FRAP)
BRCA1
associated
RING
domain
1
(BARD1)
exchange
complex
lesions.
In
summary,
presented
herein
time-efficient
wide
range
experiments
through
user-friendly
interface.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(23), P. 16903 - 16903
Published: Nov. 29, 2023
Replicative
DNA
polymerases
are
blocked
by
nearly
all
types
of
damage.
The
resulting
replication
stress
threatens
genome
stability.
is
also
caused
depletion
nucleotide
pools,
polymerase
inhibitors,
and
sequences
or
structures
that
difficult
to
replicate.
Replication
triggers
complex
cellular
responses
include
cell
cycle
arrest,
fork
collapse
one-ended
double-strand
breaks,
induction
repair,
programmed
death
after
excessive
specific
(e.g.,
G-rich
form
G-quadruplexes)
localized
but
occurs
during
the
S
phase
every
division.
This
review
focuses
on
widespread
such
as
random
damage,
inhibition/nucleotide
pool
depletion,
R-loops.
Another
global
seen
in
cancer
cells
termed
oncogenic
stress,
reflecting
dysregulated
origin
firing
and/or
progression.
often
cells,
this
too
contributes
ongoing
instability
can
drive
Nucleases
play
critical
roles
responses,
including
MUS81,
EEPD1,
Metnase,
CtIP,
MRE11,
EXO1,
DNA2-BLM,
SLX1-SLX4,
XPF-ERCC1-SLX4,
Artemis,
XPG,
FEN1,
TATDN2.
Several
these
nucleases
cleave
branched
at
stressed
forks
promote
repair
restart
forks.
We
recently
defined
for
EEPD1
restarting
oxidative
TATDN2
mitigating
R-loop
accumulation
BRCA1-defective
cells.
discuss
how
insights
into
biological
genome-wide
inform
novel
treatment
strategies
exploit
synthetic
lethal
relationships
among
response
factors.
Genes,
Journal Year:
2023,
Volume and Issue:
14(1), P. 144 - 144
Published: Jan. 5, 2023
The
DNA
Damage
Response
(DDR)
pathways
sense
damage
and
coordinate
robust
repair
bypass
mechanisms.
A
series
of
proteins
are
recruited
depending
on
the
type
breaks
lesions
to
ensure
overall
survival.
An
increase
in
glucose
levels
was
shown
induce
genome
instability,
yet
links
between
DDR
still
not
well
investigated.
In
this
study,
we
aimed
identify
dysregulation
transcriptome
normal
cancerous
breast
cell
lines
upon
changing
levels.
We
first
performed
bioinformatics
analysis
using
a
microarray
dataset
containing
triple-negative
cancer
(TNBC)
MDA-MB-231
human
mammary
epithelium
MCF10A
grown
high
(HG)
or
presence
glycolysis
inhibitor
2-deoxyglucose
(2DG).
Interestingly,
multiple
genes
were
significantly
upregulated
both
HG.
wet
lab,
remarkably
found
that
HG
results
severe
TNBC
cells
as
observed
comet
assay.
addition,
several
confirmed
be
qPCR
same
line.
Our
propose
strong
need
for
oppose
induced
cells.